期刊文献+

SIR模型在成人麻疹爆发及其疫情控制评价中的应用 被引量:6

Use of SIR model in evaluation of control measures for adults' measles outbreak
原文传递
导出
摘要 目的利用SIR模型,探讨成人麻疹爆发疫情的传播过程及疫苗控制效果。方法在一定的假设条件下,根据一定时期内实际爆发麻疹发病数,建立传染病动力学模型,利用马尔科夫蒙特卡洛算法对SIR模型进行参数估计。通过合理假设计算基本再生数(R_0)和有效再生数(R_t),研究疫苗控制效果。结果本次麻疹爆发有效接触率β=0.001 06,恢复率γ=0.117,R_0=2.96;在该模型假定条件下,如果在病例出现的第2天开始接种疫苗,可减少90.6%的病例发生,而在当前真实感染及控制措施下,该爆发在第26天时Rt<1,此时疾病即使不采取任何防治措施,亦会逐渐消失。结论 SIR模型适用于研究成人麻疹爆发过程,其在参数估计及模型拟合中接近真实情况。 Objective A susceptible-infectious-recovered (SIR) model was established to describe the process of measles outbreak, and to analyze the control effect of vaccination and optimal control strategy. Methods Under the special circumstances, we adopted Markov Chain Monte Carlo (MCMC) to estimate the parameters of the model based on the real infected numbers. We calculated the basic reproduction number (R0 ) and effective reproduction number (R,) base on rational assumptions to analyze the control effect of vaccination. Results The effective contact rate β was 0. 001 06, the recovery rate y' was 0. 117 and R0 was 2. 96. The percentage of patients could reduce by 90. 6% if emergency vaccination was used the second day after outbreak. On the 26m day, Rt 〈 1, and the disease would fade away even if there were no vaccination. Conclusion The SIR model is suitable for studying adults' measles outbreak, and it is close to real situation in estimating parameters.
出处 《山东大学学报(医学版)》 CAS 北大核心 2016年第9期87-91,共5页 Journal of Shandong University:Health Sciences
基金 山东省科技发展计划(2014GGH218019) 病原微生物生物安全国家重点实验室开放课题(SKLPBS1453) 山东省泰山学者岗位支持
关键词 传染病动力学模型 麻疹 马尔科夫蒙特卡洛 SIR模型 基础再生数 Mathematical models of infectious diseases Measles Markov Chain Monte Carlo SIR Model Basic Reproduction Number
  • 相关文献

参考文献3

二级参考文献29

  • 1迮文远.麻疹的控制与消除[J].中华流行病学杂志,1996,17(2):67-69. 被引量:76
  • 2李黎,余文周,税铁军,马超,温宁,梁晓峰.全国2003~2006年麻疹发病年龄特征分析[J].中国计划免疫,2007,13(2):101-105. 被引量:156
  • 3卫生部.2006-2012年全国消除麻疹行动计划[S].2006-11-10.
  • 4Ma C, An Z, Hao L, et al. Progress toward measles elimination in the People~ Republic of China, 2000 -2009 E Jl. J Infect Dis, 2011, 204 (Suppl 1) : S447-454.
  • 5国务院.卫生事业发展“十二五”规划[EB/OL].2012-10-08.http://www.gov.cn/zwgk/2012-10/19/content_2246908.htm.
  • 6WHO WPR. Resolution WPR/RC63.5. Elimination of measles and acceleration of rubella control [ EB/OL]. WHO WPR 2012. Avail- able at http://www, wpro. who. int/about/regional_ committee /63/ resolutions/WPR_RC63 R5 Measles_elimination_03Oct. pdf. (accessed February 2014).
  • 7WHO WPR. Guidelines on Verification of Measles Elimination in the Western Pacific Region [ EB/OL]. WHO WPR 2013. Availa- ble at: http://www, wpro. who. int/immunization/documents/mea- sles_elimination_verification_guidelines_2013/en/. ( accessed Feb- ruary 2014). 2013.
  • 8WHO. Immunization: Measles (MCV) by country [EB/OL]. ht- tp://apps, who. int/gho/data/node, main. A826. (last accessed on 6 FEB 2014).
  • 9Nokes DJ, Anderson RM. The Use of Mathematical-Models in the Epidemiological-Study of Infectious-Diseases and in the Design of Mass Immunization Programs [ J ]. Epidemiology and Infection, 1988, 101 ( 1 ) : 1-20.
  • 10Nokes D J, Anderson RM. Measles, Mumps and Rubella Vaccine - What Coverage to Block Transmission [ J ]. lancet, 1988, 2 (8624) : 1374.

共引文献279

同被引文献36

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部